CollPlant Biotechnologies Share Price Today

CollPlant subsidiary LightSolver secures $1.8 million R&D grant

CollPlant Biotechnologies Ltd. subsidiary LightSolver received a $1.8 million grant from the Israel Innovation Authority. Funding supports the development of next-generation Laser Processing Unit (LPU) hardware for solving partial differential equations. The program includes expanding LPU Lab capabilities and integrating the LPU into heterogeneous HPC environments. The grant builds on existing partnerships with Boeing and the Israel Ministry of Defense, as well as funding from the European Innovation Council. CollPlant plans to rename itself OptiPhi Computing Ltd. and change its ticker to OPHI, pending approvals.

CollPlant Biotechnologies Q2 Results: Adj. EPS $(1.69) misses estimate

Adjusted loss per share widened to $1.69, missing estimates by 604.17%. Quarterly sales fell 39.66% YoY to $108.000 thousand. Revenue missed analyst consensus of $1.466 million by 92.63%. Losses increased 26.52% compared to $(2.30) per share in prior year.

CollPlant Biotechnologies regains Nasdaq listing compliance

CollPlant Biotechnologies regained compliance with Nasdaq Listing Rule 5550(a)(2). The company's common stock now maintains the required minimum bid price of $1.00. Formal notification was received from The Nasdaq Stock Market LLC.

CollPlant Biotechnologies approves 1-for-10 reverse share split for Nasdaq compliance

CollPlant Biotechnologies approved a one-for-ten reverse share split. Split effective when Nasdaq Capital Market opens on September 4, 2026. Shares will trade under existing ticker symbol CLGN on adjusted basis. Move aims to regain compliance with Nasdaq minimum bid price requirement. Shareholders approved action at meeting held on August 18, 2026.

CollPlant Biotechnologies files prospectus for 31.047M share offering

CollPlant Biotechnologies filed a prospectus for an offering of 31.047M shares on behalf of selling shareholders. The filing was submitted to the SEC.

CollPlant Biotechnologies launches $2.6M offering of shares and warrants

CollPlant Biotechnologies has launched a private placement to issue 7,647,061 ordinary shares along with series A and series B warrants, aiming to raise approximately $2.6 million in gross proceeds. The securities are priced at $0.34 per share, with warrants exercisable upon shareholder approval and expiring two to five years post-registration. The company plans to use the net proceeds for working capital, research and development, and evaluating strategic business combinations.